Literature DB >> 9154370

Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study.

J G Rabkin1, S J Ferrando, L B Jacobsberg, B Fishman.   

Abstract

The primary purpose of this study was to assess the prevalence of major psychiatric disorders in human immunodeficiency virus-positive (HIV+) men with acquired immune deficiency syndrome (AIDS)-defining conditions. Secondary goals were to identify correlates of distress and psychopathology, and to determine whether there is a gradient of distress associated with progressive HIV illness. One hundred twelve men with AIDS-defining conditions, 61 HIV+ men without AIDS, and 84 HIV-seronegative gay men were assessed. Measures included the Structured Clinical Interview for DSM-IV (SCID), Hamilton Rating Scale for Depression (HAM-D), and other dimensional measures of distress and outlook, as well as laboratory markers of HIV stage, including HIV RNA viral load assays. Rates of major depression, consistent with other findings, were in the 5% to 10% range. Mean scores on dimensional measures of distress and outlook were within the "not depressed" range and did not increase despite increasing HIV illness severity. However, rates of dysthymia were elevated among men with CD4 cell counts less than 500, and the cumulative rates of any current axis I depressive disorder for three of the four study groups were in the range of 15% to 20%. The strongest correlates of dimensional measures of distress were current HIV symptoms and social support, and to a lesser extent, a lifetime history of major depression and current use of antidepressants and/or anxiolytics. Overall, most men displayed effective adaptation to illness, but a significant minority experienced moderate psychological distress, which warrants consideration by health providers who serve this population.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154370     DOI: 10.1016/s0010-440x(97)90067-5

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  26 in total

1.  Psychiatric diagnoses in a sample of HIV-infected people of color in methadone treatment.

Authors:  Mark G Winiarski; Lori I Greene; Alec L Miller; Nancy B Palmer; Jesus Salcedo; Maite Villanueva
Journal:  Community Ment Health J       Date:  2005-08

2.  The role of illness, resources, appraisal, and coping strategies in adjustment to HIV/AIDS: the direct and buffering effects.

Authors:  K I Pakenham; M Rinaldis
Journal:  J Behav Med       Date:  2001-06

Review 3.  Neuropsychiatric aspects of HIV infection among older adults.

Authors:  C H Hinkin; S A Castellon; J H Atkinson; K Goodkin
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

5.  Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems.

Authors:  John Orwat; Richard Saitz; Christopher P Tompkins; Debbie M Cheng; Michael P Dentato; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2011-06-22

Review 6.  [Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders].

Authors:  Hans-Bernd Rothenhäusler
Journal:  Wien Med Wochenschr       Date:  2006-12

7.  Human immunodeficiency virus and depression in primary care: a clinical review.

Authors:  Tiziano Colibazzi; Teresa T Hsu; William S Gilmer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

8.  The mental health impact of AIDS-related mortality in South Africa: a national study.

Authors:  L Myer; S Seedat; D J Stein; H Moomal; D R Williams
Journal:  J Epidemiol Community Health       Date:  2008-12-15       Impact factor: 3.710

9.  The interaction of mindful-based attention and awareness and disengagement coping with HIV/AIDS-related stigma in regard to concurrent anxiety and depressive symptoms among adults with HIV/AIDS.

Authors:  Adam Gonzalez; Sondra E Solomon; Michael J Zvolensky; Carol T Miller
Journal:  J Health Psychol       Date:  2009-04

10.  Neurocognition in individuals co-infected with HIV and hepatitis C.

Authors:  Charles H Hinkin; Steven A Castellon; Andrew J Levine; Terry R Barclay; Elyse J Singer
Journal:  J Addict Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.